losartan and salicylates

losartan has been researched along with salicylates in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diezi, J; Guisan, B; Roch-Ramel, F1
Akçit, F; Cağlar, S; Cetin, A; Ozturk, OH; Tokay, A; Yeşilkaya, A1

Other Studies

2 other study(ies) available for losartan and salicylates

ArticleYear
Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: Aged; Benzbromarone; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Diuretics; Ethambutol; Humans; Imidazoles; Kidney Cortex; Kidney Neoplasms; Kinetics; Losartan; Microvilli; Middle Aged; Probenecid; Pyrazinamide; Salicylates; Salicylic Acid; Sulfinpyrazone; Tetrazoles; Ticrynafen; Uric Acid; Uricosuric Agents

1997
Angiotensin II-induced MAPK phosphorylation mediated by Ras and/or phospholipase C-dependent phosphorylations but not by protein kinase C phosphorylation in cultured rat vascular smooth muscle cells.
    Pharmacology, 2007, Volume: 79, Issue:1

    Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Farnesol; Indoles; Losartan; Male; Maleimides; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinase C; Pyrrolidinones; ras Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Salicylates; Time Factors; Type C Phospholipases

2007